Schedule 13G ownership disclosure

NEUPHORIA THERAPEUTICS INC

Common Stock, $0.00001 par value per share · CUSIP: 64136E102

Event date: 2025-10-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Baselake Partners, LP

    Shares: 222,222 · Class: 9.4%

  • Baselake Management, LLC

    Shares: 222,222 · Class: 9.4%

  • David Paolella

    Shares: 222,222 · Class: 9.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001957912-25-000007
Form type
SCHEDULE 13G
Filer
Baselake Partners, LP
CIK
CIK 1957912
Filed
Oct 31, 2025
Reporting period
Oct 27, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub